Clinicopathological Study of Gynecologic Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Clinical Research of Cancer".
Deadline for manuscript submissions: 30 June 2024 | Viewed by 1039
Special Issue Editor
Interests: cervical cancer; human papillomavirus; HPV; gynecologic oncology; preventive oncology; CIN; cervical intraepithelial neoplasia
Special Issue Information
Dear Colleagues,
Gynecological malignancies are a critical global challenge, as at present high mortality rates due to lack of early diagnosis are reported in many countries. In recent years, significant milestones have been achieved in terms of uncovering the biology and the natural history of neoplasms. For example, it is now known that understanding the mechanisms of human papillomavirus can aid in the diagnosis and curing of different histological subtypes of cervical cancer. Additionally, genetic alterations play an important causal role in the development and progression of endometrial and ovarian cancers, and environmental factors, such as the genital microbiome, further exacerbate them. Given these findings, both biological and clinical research have increasingly focused on the identification and validation of biomolecular, pathological and omics parameters associated with the higher risk of cancer development in females; to an extent, such research has led to clinically relevant improvements in terms of persistence/recurrence rates and better survival rates. Therefore, in this Special Issue, we cordially invite submissions of original research and comprehensive review articles focusing on the promising results found in recent biological and clinical research which have the potential to improve clinical practice and patients’ treatment, thereby enhancing the management of female genital cancers.
Dr. Origoni Massimo
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gynecological oncology
- gynaecological cancer
- female cancer
- uterine cancer
- ovarian cancer
- endometrial cancer
- cancerogenesis
- cancer biology
- cell transformation
- cancer pathology
- cancer biology
